Given Bcl-6+ hTregs’ complex and dual role in tumor immunity, further investigation into Bcl-6+ hTregs is crucial to understanding their impact on antibody responses and potential therapeutic strategies in cancer treatment. This evidence concerns the gene BCL6 and neoplasm.